Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Ancell
anti-CD13 (human), mAb (22A5) (APC)
551
CHF
CHF 551.00
In stock
ANC-162-060120 testsCHF 551.00
Product Details | |
---|---|
Synonyms | Aminopeptidase N; AP-N; Myeloid Plasma Membrane Glycoprotein CD13; gp150 |
Product Type | Monoclonal Antibody |
Properties | |
Clone | 22A5 |
Isotype | Mouse IgG2aκ |
Source/Host | Purified from concentrated hybridoma tissue culture supernatant. |
Immunogen/Antigen | Human osteosarcoma tissue. |
Label/Conjugates | APC |
Application |
Flow Cytometry |
Crossreactivity | Human |
Specificity |
Recognizes the human cell surface aminopeptidase N enzyme [CD13]. |
Concentration | 0.5mg/ml |
Formulation | 50mM Sodium Phosphate pH 7.5, 500mM Potassium Chloride, 150mM NaCl, 15% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative). |
Isotype Negative Control | |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Accession Number | P15144 |
Declaration | Manufactured by Ancell Corporation. |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice |
Do not freeze. Protect from light. |
Use/Stability | Stable for at least 1 year after receipt when stored at +4°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
Human CD13 is a zinc-binding aminopeptidase-N enzyme expressed on the surface of myeloid cells. IL-4 will upregulate expression of CD13 which may play an anti-inflammatory role.